-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Tizanidine hydrochloride is a pharmaceutical drug that is primarily used for the treatment of spasticity and muscle stiffness.
It is a central nervous system (CNS) relaxant that works by blocking the actions of neurotransmitters, including acetylcholine and GABA, which are involved in the control of muscle activity.
Tizanidine hydrochloride is classified as a skeletal muscle relaxant and is often prescribed for the treatment of conditions such as multiple sclerosis, spinal cord injury, and Parkinson's disease.
The manufacturing process for tizanidine hydrochloride involves several steps, including the synthesis of the active ingredient and the formation of the hydrochloride salt.
The synthesis of tizanidine hydrochloride involves the use of several chemical reactions, including condensation, substitution, and reduction reactions.
The first step in the synthesis of tizanidine hydrochloride involves the condensation of 2-chloromethyl-5,6-dimethoxy-tetrahydro-isoquinoline with methyl 2-chloro-5,6-dimethoxy-tetrahydro-isoquinoline acetate.
This reaction is carried out in the presence of a solvent, such as ethyl acetate, and is followed by the isolation of the desired product.
The next step in the synthesis of tizanidine hydrochloride involves the substitution of the methyl group in the previous compound with a hydroxy group.
This is accomplished through the use of a hydroxylating agent, such as sodium hydroxide, in the presence of a solvent, such as methanol.
The final step in the synthesis of tizanidine hydrochloride involves the reduction of the nitro group in the previous compound to form the corresponding amine.
This is accomplished through the use of a reducing agent, such as lithium aluminum hydride, in the presence of a solvent, such as ether.
Once the synthesis of tizanidine hydrochloride is complete, the next step involves the formation of the hydrochloride salt.
This is done by treating the synthesized compound with hydrochloric acid, and the resulting salt is then isolated and dried.
The purification process for tizanidine hydrochloride involves the use of several chromatography techniques, including high-performance liquid chromatography (HPLC) and flash chromatography.
These techniques are used to separate the desired product from any impurities that may be present, and to increase the purity of the final product.
The quality of tizanidine hydrochloride is determined through a series of tests, including assay, dissolution, and stability testing.
Assay testing is used to determine the amount of active ingredient present in the final product, while dissolution testing is used to assess the rate at which the active ingredient is released from the tablet or capsule.
Stability testing is used to determine how well the product retains its properties over time.
Tizanidine hydrochloride is a prescription medication that is available in the form of tablets and capsules.
It is taken orally and is usually prescribed for the treatment of muscle spasticity and stiffness.
It is important to follow the instructions provided by your healthcare provider when taking tizanidine hydrochloride, as it can cause side effects, including dizziness, drowsiness, and dry mouth.
In conclusion, tizanidine hydrochloride is a pharmaceutical drug that is used for the treatment of spasticity and muscle stiffness.
The manufacturing process involves several steps, including the synthesis of the active ingredient and the formation of the hydrochloride salt.
The purification process uses chromatography techniques to increase the purity of the final product